Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 14, 2012; 18(30): 4004-4011
Published online Aug 14, 2012. doi: 10.3748/wjg.v18.i30.4004
Published online Aug 14, 2012. doi: 10.3748/wjg.v18.i30.4004
Table 6 Sensitivity of faecal pyruvate kinase isoenzyme type M2 for adenoma n (%)
| Reference | Adenoma without diameter | Adenoma < 1 cmø | Adenoma > 1 cmø |
| Naumann et al[45], 2004 | 11 (27.3) | 13 (61.5) | |
| McLoughlin et al[51], 2005 | 30 (76) | ||
| Vogel et al[44], 2005 | 21 (48) | ||
| Shastri et al[7], 2006 | 21 (28.6) | 10 (20.0) | |
| Mulder et al[35], 2007 | 47 (28) | ||
| Koss et al[8], 2008 | 5 (20) | 5 (60) | |
| Shastri et al[31], 2008 | 48 (29.2) | 21 (57.1) | |
| Haug et al[30], 2008 | 254 (22.1) | 68 (23.5) | |
| Sum | 98 | 339 | 117 |
| mean ± SD | 51 ± 24 | 25 ± 4 | 44 ± 21 |
- Citation: Tonus C, Sellinger M, Koss K, Neupert G. Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: A meta-analysis. World J Gastroenterol 2012; 18(30): 4004-4011
- URL: https://www.wjgnet.com/1007-9327/full/v18/i30/4004.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i30.4004